Anti-Mullerian Hormone and Use in General Practice

Learn about the role and clinical significance of Anti-Mullerian Hormone (AMH) in reproductive health in this fertility presentation.

This is a RACGP CPD module with an allocated 0.5 hour of Education Activities (EA) and 1 hour of Reflective Practice (RP) under the RACGP 2023-25 CPD program.

Learning Objectives:

1. Review the role of Anti-Mullerian Hormone (AMH) testing in female fertility 
2. Discuss the testing limitations and when to use/avoid
3. Discuss how to interpret AMH testing and educate patients on results/impact on fertility

This activity is presented by Dr James Brown, a Fertility Specialist & Gynaecologist at the Norwest Private Hospital, Westmead Private Hospital, and Lakeview Private Hospital.

This presentation was recorded in March 2024.

*If you’d like to watch this presentation alone without doing the CPD Activity, click here.